David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBA
2526
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $887K | ﹤0.01% |
40,899
-33,609
| -45% | -$702K |
|
2527
Mitek Systems
MITK
$798M
| $884K | ﹤0.01% |
93,035
-39,786
| -30% | -$389K |
|
2528
IDT Corp
IDT
$1.71B
| $880K | ﹤0.01% |
+73,909
| New | +$911K |
|
2529
Alaunos Therapeutics
TCRT
$4.5M
| $880K | ﹤0.01% |
956
+830
| +659% | +$737K |
|
2530
Mizuho Financial
MFG
$126B
| $879K | ﹤0.01% |
247,663
+89,996
| +57% | +$316K |
|
2531
National Bank Holdings
NBHC
$1.85B
| $877K | ﹤0.01% |
24,560
-667
| -3% | -$22.1K |
|
2532
Aon
AON
$75.4B
| $873K | ﹤0.01% |
5,978
-40,934
| -87% | -$5.71M |
|
2533
OR Royalties Inc
OR
$7.22B
| $872K | ﹤0.01% |
67,585
-271,550
| -80% | -$3.51M |
|
2534
Global Payments
GPN
$24.9B
| $871K | ﹤0.01% |
9,161
-39
| -0.4% | -$3.67K |
|
|
IRBT
2535
CALL
DELISTED
iRobot
IRBT
| $871K | ﹤0.01% |
11,300
-41,300
| -79% | -$3.78M |
|
2536
PUT
Regions Financial
RF
$26B
| $870K | ﹤0.01% |
57,100
-94,000
| -62% | -$1.35M |
|
|
FRC
2537
DELISTED
First Republic Bank
FRC
| $870K | ﹤0.01% |
8,331
-48,914
| -85% | -$4.86M |
|
2538
Franco-Nevada
FNV
$52.4B
| $869K | ﹤0.01% |
11,208
-122,138
| -92% | -$9.38M |
|
2539
United Parks & Resorts
PRKS
$2.02B
| $866K | ﹤0.01% |
66,680
-364
| -0.5% | -$4.98K |
|
|
QEP
2540
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $866K | ﹤0.01% |
101,000
-13,100
| -11% | -$107K |
|
|
KLXI
2541
DELISTED
KLX Inc.
KLXI
| $865K | ﹤0.01% |
+19,372
| New | +$822K |
|
|
AGFS
2542
DELISTED
AgroFresh Solutions Inc
AGFS
| $864K | ﹤0.01% |
122,952
+9,227
| +8% | +$69.2K |
|
|
AVX
2543
DELISTED
AVX Corporation
AVX
| $860K | ﹤0.01% |
47,169
-28,305
| -38% | -$491K |
|
2544
CALL
DXC Technology
DXC
$1.7B
| $859K | ﹤0.01% |
11,560
| – | – |
|
2545
CALL
Dycom Industries
DY
$10.7B
| $859K | ﹤0.01% |
10,000
| – | – |
|
2546
W.W. Grainger
GWW
$61.6B
| $858K | ﹤0.01% |
4,774
-14,644
| -75% | -$2.47M |
|
2547
PUT
Invesco Mortgage Capital
IVR
$795M
| $857K | ﹤0.01% |
5,000
| – | – |
|
2548
E.W. Scripps
SSP
$306M
| $857K | ﹤0.01% |
44,826
+2,623
| +6% | +$48.1K |
|
2549
Barings BDC
BBDC
$985M
| $856K | ﹤0.01% |
+59,925
| New | +$903K |
|
2550
IPG Photonics
IPGP
$3.03B
| $856K | ﹤0.01% |
4,623
-18,437
| -80% | -$3.06M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.